Entero Healthcar
Medical Distribution · ENTERO
Small CapHealthcareHigh Growth
Prabhat Agrawal
Managing Director & Chief Executive Officer · Pragmatic
Company DNA
Performance-Driven
About
Entero Healthcar is a Small Cap company in the Healthcare sector, listed on NSE as ENTERO. With a market cap of ₹5K Cr and revenue of ₹5K Cr, it is currently in the High Growth phase. Known for its Performance-Driven culture and Fast-Follower approach to innovation, the company operates at a Startup-Speed pace. Fast-growing healthcare distribution player focused on scaling market share, aggressive supply chain management, and high-frequency operational execution. Its strategic mandate: Aggressive pharmacy retail integration requires a transformation of supply chain logistics and digital customer interfaces to capture fragmented market share.
FAQ
What kind of company is Entero Healthcar?
Entero Healthcar is a Small Cap Healthcare company (ENTERO) in the High Growth phase with a market cap of ₹5K Cr. It is classified as Performance-Driven in culture.
What is Entero Healthcar's culture and work environment like?
Entero Healthcar has a Performance-Driven culture with Fast-Follower innovation DNA and a Startup-Speed pace of execution. Employee brand: Demanding Machine. Customer relationship style: B2B-Enterprise. Fast-growing healthcare distribution player focused on scaling market share, aggressive supply chain management, and high-frequency operational execution.
Who leads Entero Healthcar?
Entero Healthcar is led by Prabhat Agrawal (Managing Director & Chief Executive Officer), a Pragmatic leader with 26 years of experience.
What are Entero Healthcar's financials?
Entero Healthcar reported revenue of ₹5K Cr in FY25 with a 5-year revenue CAGR of 26.3%. Operating margin: 2.8%. Market cap: ₹5K Cr.
Culture & Strategy
CulturePerformance-Driven
InnovationFast-Follower
PaceStartup-Speed
PurposePurpose-Blended
CustomerB2B-Enterprise
EmployeeDemanding Machine
BrandTechnical-Expert
LifecycleHigh Growth
Fast-growing healthcare distribution player focused on scaling market share, aggressive supply chain management, and high-frequency operational execution.
Mandate
Aggressive pharmacy retail integration requires a transformation of supply chain logistics and digital customer interfaces to capture fragmented market share.
Aggressive pharmacy retail integration requires a transformation of supply chain logistics and digital customer interfaces to capture fragmented market share.
Financials
Revenue FY25₹5K Cr
PAT FY25₹95 Cr
Rev CAGR 5Y26.3%
OPM2.8%
NPM1.9%
ROE5.5%
ROCE7.7%
P/E39.2
Fwd P/E22.7
P/B2.5
D/E24.6
Mkt Cap₹5K Cr
Promoter66%
Institutional16.2%
Similar Culture
Could You Lead Entero Healthcar?
Take the Genome Benchmark →